Apraxia Market Research Report- Global Forecast till 2023

Apraxia Market Research Report- Global Forecast till 2023

ID: MRFR/HC/3444-HCRR | | Region: Global | 115 pages | Half-Cooked Research Reports

Apraxia Market Information: By Type (Ideomotor Apraxia, Ideational/Conceptual Apraxia), By Diagnosis (Test To Measure Upper Limb Apraxia, MRI), Treatment (Speech Therapy), End User (Hospitals & Clinics, Research Centers) - Global Forecast Till 2023 


Market Scenario


Apraxia is a neurological condition. Also, it is known as a motor disorder caused by damage to the brain. In this case, patients who find it difficult or impossible to make certain motor movements, even though their muscles are normal. Apraxia can occur in different forms one of which is orofacial apraxia. In which, patients are unable to voluntarily perform certain movements involving facial muscles. For instance, they may not be able to wink. Another form of apraxia affects a patient’s ability to intentionally move arms and legs.


Whereas in children apraxia of speech (CAS) has a number of possible causes, but in many cases, the cause can't be determined and often don't observe a problem in the brain of a child with CAS. CAS may be the result of brain (neurological) conditions or injuries, such as a stroke, infections or traumatic brain injury.


The apraxia market growth is majorly attributed to the increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of various neurological diseases are likely to fuel the market growth during the forecast period.


According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


However, the high cost of this treatment procedure may hamper the market growth during the corresponding period.


The global apraxia market is expected to grow at a CAGR of ~ 6.4 % during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers

  • Potential Investors 


 Figure: Global Apraxia Market, By Region Market Share, 2016 (%)

Apraxia Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations
The global apraxia market has been segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of the types, the market is segmented into ideomotor apraxia, ideational/conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, apraxia of speech.


On the basis of the diagnosis, the market is segmented into a test to measure upper limb apraxia, MRI, and others.


On the basis of the treatment, the market is segmented into speech therapy, occupational therapy, physical therapy, and others.


On the basis of the ‘end user, the market is segmented into hospitals & clinics, research centers, and others. 


Regional Analysis
The Americas dominate the global apraxia market owing to well-developed technology, increasing prevalence of neurological disorders, high health care spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the global apraxia market. The government support for research & development and availability of funds for research are projected to drive the market in Europe region over the review period.  


Asia Pacific is the fastest growing apraxia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries like China, India, Japan, and South Korea will make this as emerging and the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is likely to lead the use of advanced equipment, which, in turn, will increase the growth of the market in the region.


On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.


Key Players
Some of key the players in the market are Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation and others. 


Research Methodology


Global Apraxia Market


Sources: Annual reports, Press release, White paper, and Company presentation

 Table of Content    

1.    Report Prologue    

2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

6.    Global Apraxia Market, by Type

     6.1    Introduction

      6.2    Ideomotor Apraxia

Market Estimates & Forecast, 2017-2023

      6.3    Ideational/Conceptual apraxia

Market Estimates & Forecast, 2017-2023

      6.4    Buccofacial or Orofacial Apraxia

Market Estimates & Forecast, 2017-2023

      6.5    Constructional Apraxia

Market Estimates & Forecast, 2017-2023

      6.6    Gait Apraxia

Market Estimates & Forecast, 2017-2023

      6.7    Limb-kinetic Apraxia

Market Estimates & Forecast, 2017-2023

      6.8    Apraxia of Speech

Market Estimates & Forecast, 2017-2023

7.    Global Apraxia Market, by Diagnosis

     7.1    Introduction

      7.2    Test to Measure Upper Limb Apraxia

Market Estimates & Forecast, 2017-2023

      7.3    MRI

Market Estimates & Forecast, 2017-2023

      7.4    Others

Market Estimates & Forecast, 2017-2023

8.    Global Apraxia Market, by Treatment

     8.1    Introduction

      8.2    Speech Therapy

Market Estimates & Forecast, 2017-2023

      8.3    Occupational Therapy

Market Estimates & Forecast, 2017-2023

      8.4    Physical Therapy

Market Estimates & Forecast, 2017-2023

9.    Global Apraxia Market, by End User

      9.1    Introduction

      9.2    Hospitals & Clinics

Market Estimates & Forecast, 2017-2023

      9.3    Research Centers

Market Estimates & Forecast, 2017-2023

      9.4    Others 

Market Estimates & Forecast, 2017-2023

10.    Global Apraxia Market, by Region

      10.1    Introduction

      10.2    Americas

            10.2.1    North America

                10.2.1.1    U.S.

                10.2.1.1    Canada

            10.2.2    South America

      10.3    Europe

            10.3.1    Western Europe

                10.3.1.1    Germany

                10.3.1.2    France

                10.3.1.3    UK

                10.3.1.4    Italy

                10.3.1.5    Spain

                10.3.1.6    Rest of Western Europe

            10.3.2    Eastern Europe

      10.4    Asia Pacific

            10.4.1    Japan

            10.4.2    China

            10.4.3    India

            10.4.4    Australia

            10.4.5    Republic of Korea

            10.4.6    Rest of Asia Pacific

      10.5    The Middle East & Africa

            10.5.1    United Arab Emirates

            10.5.2     Saudi Arabia

            10.5.3    Oman

            10.5.4    Kuwait

            10.5.5    Qatar

            10.5.6    Rest of the Middle East & Africa

11    Company Landscape    

      11.1    Introduction    

      11.2    Market Share Analysis    

      11.3    Key Development & Strategies    

            11.3.1    Key Developments    

12    Company Profiles    

      12.1    Medtronic Plc.    

            12.1.1    Company Overview    

            12.1.2    Product Overview    

            12.1.3    Financials    

            12.1.4    SWOT Analysis    

      12.2    Codman & Shurtleff, Inc.    

            12.2.1    Company Overview    

            12.2.2    Product Overview    

            12.2.3    Financial Overview    

            12.2.4    Key Developments    

            12.2.5    SWOT Analysis    

      12.3    Raumedic AG    

            12.3.1    Company Overview    

            12.3.2    Product Overview    

            12.3.3    Financial Overview

            12.3.4    Key Development    

            12.3.5    SWOT Analysis    

      12.4     Spiegelberg GmbH

            12.4.1    Company Overview    

            12.4.2    Product/Business Segment Overview    

            12.4.3    Financial Overview    

            12.4.4    Key Development    

            12.4.5    SWOT Analysis    

      12.5    Vittamed, Sophysa Ltd

            12.5.1    Company Overview    

            12.5.2    Product Overview    

            12.5.3    Financial overview    

            12.5.4    Key Developments    

      12.6    MicroPort Scientific Corporation

            12.6.1    Company Overview    

            12.6.2    Product Overview    

            12.6.3    Financial Overview    

            12.6.4    Key Developments    

      12.7    Orsan Medical Technologies

            12.7.1    Overview    

            12.7.2    Product Overview    

            12.7.3    Financials    

            12.7.4    Key Developments    

            12.7.5    SWOT Analysis    

    12.8    Others

13    MRFR Conclusion    

      13.1    Key Findings    

            13.1.1    From CEO’s View Point    

            13.1.2    Unmet Needs of the Market    

      13.2    Key Companies to Watch    

      13.3    Prediction of Pharmaceutical Industry

14    Appendix

LIST OF TABLES

Table 1        Apraxia Industry Synopsis, 2017-2023

Table 2        Global Apraxia Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3        Global Apraxia Market by Region, 2017-2023, (USD Million)

Table 4        Global Apraxia Market by Types, 2017-2023, (USD Million)

Table 5        Global Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 6        Global Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 7        Global Apraxia Market by End Users, 2017-2023, (USD Million)

Table 8        North America Apraxia Market by Types, 2017-2023, (USD Million)

Table 9        North America Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 10    North America Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 11    North America Apraxia Market by End Users, 2017-2023, (USD Million)

Table 12    US Apraxia Market by Types, 2017-2023, (USD Million)

Table 13    US Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 14    US Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 15    US Apraxia Market by End Users, 2017-2023, (USD Million)

Table 16    Canada Apraxia Market by Types, 2017-2023, (USD Million)

Table 17    Canada Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 18    Canada Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 19    Canada Apraxia Market by End Users, 2017-2023, (USD Million)

Table 20    South America Apraxia Market by Types, 2017-2023, (USD Million)

Table 21    South America Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 22    South America Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 23    South America Apraxia Market by End Users, 2017-2023, (USD Million)

Table 24    Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 25    Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 26    Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 27    Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 28    Western Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 29    Western Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 30    Western Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 31    Western Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 32    Eastern Europe Apraxia Market by Types, 2017-2023, (USD Million)

Table 33    Eastern Europe Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 34    Eastern Europe Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 35    Eastern Europe Apraxia Market by End Users, 2017-2023, (USD Million)

Table 36    Asia Pacific Apraxia Market by Types, 2017-2023, (USD Million)

Table 37    Asia Pacific Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 38    Asia Pacific Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 39    Asia Pacific Apraxia Market by End Users, 2017-2023, (USD Million)

Table 40    Middle East & Africa Apraxia Market by Types, 2017-2023, (USD Million)

Table 41    Middle East & Africa Apraxia Market by Diagnosis, 2017-2023, (USD Million)

Table 42    Middle East & Africa Apraxia Market by Treatment, 2017-2023, (USD Million)

Table 43    Middle East & Africa Apraxia Market by End Users, 2017-2023, (USD Million)



LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Apraxia Market

Figure 3    Segmentation Market Dynamics for Apraxia Market

Figure 4    Global Apraxia Market Share, by Diagnosis 2016

Figure 5    Global Apraxia Market Share, by Treatment 2016

Figure 6    Global Apraxia Market Share, by End Users, 2016

Figure 7    Global Apraxia Market Share, by Region, 2016

Figure 8    North America Apraxia Market Share, by Country, 2016

Figure 9    Europe Apraxia Market Share, by Country, 2016

Figure 10    Asia Pacific Apraxia Market Share, by Country, 2016

Figure 11    Middle East & Africa Apraxia Market Share, by Country, 2016

Figure 12    Global Apraxia Market: Company Share Analysis, 2016 (%)

Figure 13    Medtronic Plc: Key Financials

Figure 14    Medtronic Plc: Segmental Revenue

Figure 16    Medtronic Plc: Geographical Revenue

Figure 17    Codman & Shurtleff, Inc: Key Financials

Figure 18    Codman & Shurtleff, Inc: Segmental Revenue

Figure 19    Codman & Shurtleff, Inc: Geographical Revenue

Figure 20    Raumedic AG: Key Financials

Figure 21    Raumedic AG: Segmental Revenue

Figure 22    Raumedic AG: Geographical Revenue

Figure 23    Vittamed, Sophysa Ltd: Key Financials

Figure 24    Vittamed, Sophysa Ltd: Segmental Revenue

Figure 25    Vittamed, Sophysa Ltd: Geographical Revenue

Figure 26    Spiegelberg GmbH: Key Financials

Figure 27    Spiegelberg GmbH: Segmental Revenue

Figure 28    Spiegelberg GmbH: Geographical Revenue

Figure 29    MicroPort Scientific Corporation: Key Financials

Figure 30    MicroPort Scientific Corporation: Segmental Revenue

Figure 31    MicroPort Scientific Corporation: Geographical Revenue

Figure 32    Orsan Medical Technologies: Key Financials

Figure 33    Orsan Medical Technologies: Segmental Revenue

Figure 34    Orsan Medical Technologies: Geographical Revenue